Publications
LEO Pharma employees were authors or co-authors on the following publications.
2013
Disease quantification in dermatology: in vivo near-infrared spectroscopy measures correlate strongly with the clinical assessment of psoriasis severity Read more
Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses Read more
Operationalization and application of “early warning signs” to screen nanomaterials for harmful properties Read more
Identification and mapping of a linear epitope of centromere protein F using monoclonal antibodies Read more
A lentiviral vector-based genetic sensor system for comparative analysis of permeability and activity of vitamin D3 analogues in xenotransplanted human skin Read more
2012
Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Part 1 Read more
Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Part 2 Read more
In-vitro evaluation of the P-glycoprotein interactions of a series of potentially CNS-active Amaryllidaceae alkaloids Read more
Humanized mouse model of skin inflammation is characterized by disturbed keratinocyte differentiation and influx of IL-17A producing T cells Read more
Psoriasis drug discovery - methods for evaluation of potential drug candidates Read more
Effect of low molecular weight heparins (LMWHs) on antiphospholipid antibodies (aPL) – mediated inhibition of endometrial angiogenesis Read more
Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammation Read more
Development of transgenic cloned pig models of skin inflammation by DNA transposon-directed ectopic expression of human β1 and α2 integrin Read more
Comparison of microRNA expression using different preservation methods of matched psoriatic skin samples Read more
Allergic contact dermatitis induces upregulation of identical microRNAs in humans and mice Read more
Melanin concentrating hormone receptor 1 (MCHR1) antagonists—Still a viable approach for obesity treatment? Read more
Translating clinical activity and gene expression signatures of etanercept and ciclosporin to the psoriasis xenograft SCID mouse model Read more
Ingenol mebutate gel for actinic keratosis Read more
Emerging nonanticoagulant role of low molecular weight heparins on extravillous trophoblast functions and on heparin binding-epidermal growth factor and cystein-rich angiogenic inducer 61 expression Read more
Semisynthesis of ingenol 3-angelate (PEP005): Efficient stereoconservative angeloylation of alcohols Read more
Design of cyclic RKKH peptide-conjugated PEG liposomes targeting the integrin α2β1 receptor Read more
Comparison of the antipsoriatic effect and tolerability of calcipotriol-contaning products in the treatment of psoriasis vulgaris using a modified psoriasis plaque test Read more
Calcipotriol delivery into the skin with PEGylated liposomes Read more
Ingenol mebutate-induced cell death patterns in normal and cancer epithelial cells Read more
2011
JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis Read more
IL-25 in atopic dermatitis - a possible link between inflammation and skin barrier dysfunction? Read more
IL-23-mediated epidermal hyperplasia is dependent on IL-6 Read more
Drug design of GPCR ligands using physicogenetics and chemogenomics - principles and case studies Read more
In vitro penetration properties of solid nanoparticles in intact and barrier-impaired skin Read more
Protamine neutralisation of low molecular weight heparins and their oligosaccharide components Read more
Targeting of liposome-associated calcipotriol to the skin: effect of liposomal membrane fluidity and skin barrier integrity Read more
A sleeping beauty DNA transposon-based genetic sensor for functional screening of vitamin D3 analogues Read more
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL) Read more
CD4+ T cell depletion changes the cytokine environment from a TH1/TH2 response to a TC17-like response in a murine model of atopic dermatitis Read more
Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland Read more
The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: a systematic review of direct and indirect evidence Read more
Heterogeneity in the treatment of moderately severe scalp psoriasis in Scotland: results of a survey of Scottish health professionals Read more
Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris Read more
A psoriasis-specific model to support decision making: UK experience Read more